+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients



Induction of killer cells from lymphocytes in pleural effusion of advanced lung cancer patients



Japanese Journal of Cancer Research 81(10): 1012-1020



We analyzed the phenotype and cytotoxic ability of pleural exudative lymphocytes (PLEL) which were obtained from 18 advanced lung cancer patients. Freshly isolated PLEL were mainly CD4(+) T cells and had weak natural killer, autologous tumor killing and lymphokine-activated killer activities. After cultivation of PLEL with interleukin-2, cytotoxicity of PLEL against autologous tumor cells was increased at 2 weeks, but it was remarkably reduced at 4 weeks. When PLEL were stimulated by mitomycin C-treated autologous tumor cells during culture, autologous tumor killing activity of PLEL was significantly enhanced even after 4 weeks of cultivation. Cold target inhibition analysis and binding inhibition assays using monoclonal antibodies indicated that autologous tumor stimulation could induce major histocompatibility complex class I restricted cytotoxic T lymphocytes specific for autologous tumor cells in some cases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007450963

Download citation: RISBibTeXText

PMID: 2172193

DOI: 10.1111/j.1349-7006.1990.tb03339.x


Related references

Lymphokine il 2 activated killer lak induction and its regulation in malignant pleural effusion of lung cancer patients. Proceedings of the American Association for Cancer Research Annual Meeting 30: 373, 1989

Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 103(6): 1732-1738, 1993

Development of Cytotoxic Cells during in vitro Cultures of Pleural Effusion Lymphocytes from Patients with Lung Cancer. Oncology 39(4): 201-204, 1982

Development of cytotoxic cells during in vitro cultures of pleural effusion lymphocytes from patients with lung cancer. Oncology 39(4): 201-204, 1982

Induction of killer cells in carcinomatous pleural effusions obtained from lung cancer patients. Journal of Cancer Research & Clinical Oncology 116(Suppl. Part 1): 337, 1990

Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion. Japanese Journal Of Cancer Research. 86(9): 861-866, 1995

P3.07-011 Investigation of Autologous Tumor-Killing Effect of Effusion-Associated Lymphocytes in Malignant Pleural Effusion of Lung Cancer. Journal of Thoracic Oncology 12(11): S2301-S2302, 2017

Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients. Internal Medicine 45(11): 715-720, 2006

Intrapleural administration of LAK cells combined with rIL in the treatment of advanced lung cancer with malignant pleural effusion. Zhonghua Jiehe He Huxi Zazhi 18(2): 83-84, 1995

Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion. Zhonghua Zhong Liu Za Zhi 11(4): 294-296, 1989

P1-034: A retrospective study of patients with advanced non-small cell lung cancer and malignant pleural effusion. Journal of Thoracic Oncology 2(8): S562-S563, 2007

Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma. Plos one 9(2): E89946, 2014

Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1796-1800, 1999

Activation of Valpha24NKT cells in malignant pleural effusion in patients with lung cancer. Oncology Reports 22(3): 581-586, 2009

49P Accuracy of pleural fluid cytology in patients with malignant pleural effusion from non-small-cell lung cancer, pulmonary metastases and pleural mesothelioma. A case-control study. Journal of Thoracic Oncology 11(4 Suppl.): S75-S75, 2016